51results about "Food genetic modification" patented technology

Administration of modified transposon-based vectors has been used to achieve stable incorporation of exogenous genes into animals. These transgenic animals produce transgenic progeny. Further, these transgenic animals produce large quantities of desired molecules encoded by the transgene. Transgenic egg-laying animals produce large quantities of desired molecules encoded by the transgene and deposit these molecules in the egg.

This invention relates to amylase polypeptides, and nucleic acids encoding the polpypeptides and uses thereof. The amylases of the present invention have been engineered to have more beneficial qualities. Specifically, the amylases of the current invention show an altered thermostability.

The invention relates generally to the expression of desaturase enzymes in transgenic corn plants and compositions derived therefrom. In particular, the invention relates to the production of oils with improved omega-3 fatty acid profiles in corn plants and the seed oils produced thereby. Such oils may contain stearidonic acid, which is not naturally found in corn plants and has been shown to have beneficial effects on health.

Isolated nucleic acid fragments and recombinant constructs comprising such fragments encoding a delta-8 desaturase along with a method of making long chain polyunsaturated fatty acids (PUFAs) using this delta-8 desaturase in plants and oleaginous yeast.

Isolated nucleic acid fragments and recombinant constructs comprising such fragments encoding a delta-8 desaturase along with a method of making long chain polyunsaturated fatty acids (PUFAs) using this delta-8 desaturase in plants and oleaginous yeast.

Wheat having a reduced level of SBEIIa activity, that may have a relative high amylose content. Wheat having a mutant SBEIIa gene in the A genome. The wheat might additionally have reduced levels of SBEIIb activity. The wheat grain of this invention can be of a non-shrunken phenotype despite a lesion in the amylopectin synthesis pathway, and may also have a high relative amylose content.

Rice having reduced levels of starch branching enzymes produce grain having a high relative amylose content in the endosperm. The rice grain of this invention can be of a non-shrunken phenotype despite a lesion in the amylopectin synthesis pathway and may be transgenic or nontransgenic.

Rice having reduced levels of starch branching enzymes produce grain having a high relative amylose content in the endosperm. The rice grain of this invention can be of a non-shrunken phenotype despite a lesion in the amylopectin synthesis pathway and may be transgenic or nontransgenic.   1 GCCACCGACA TCCGCCGCAA TGCTGTGTCT CACCTCCTCTTCCTCCTCCG CGCCCGCTCC  61 GCTCCTTCCC TCTCTCGCTG ATCGACCGAG CCCGGGAATCGCGGGCGGGG GTGGCAATGT 121 TCGCCTGAGC GTGGTTTCTT CGCCGCGCCG GTCGTGGCCTGGAAAGGTCA AGACCAATTT 181 CTCAGTTCCT GCGACTGCGC GAAAAAACAA AACCATGGTGACTGTTGTGG AGGAGGTCGA 241 CCACCTTCCT ATATATGATC TGGACCCTAA GTTGGAGGAATTCAAGGATC ACTTCAACTA 301 TAGGATAAAA AGATACCTCG ACCAGAAATG CCTGATTGAAAAACATGAGG GGGGCCTTGA 361 AGAATTTTCT AAAGGCTATT TGAAGTTTGG GATTAATACAGTTGATGGTG CCACAATATA 421 TCGTGAATGG GCGCCTGCTG CACAAGAAGC ACAGCTCATTGGTGAGTTCA ATAACTGGAA 481 TGGTGCAAAA CACAAGATGG AGAAGGATAA ATTTGGCATTTGGTCAATCA AGATTTCACA 541 TGTCAATGGG AAGCCTGCCA TCCCTCACAA TTCCAAGGTTAAATTTCGCT TTAGGCATGG 601 GGGTGGAGCA TGGGTTGATC GTATTCCCGC ATGGATTCGTTATGCAACTT TTGATGCCTC 661 TAAATTTGGA GCTCCATATG ATGGTGTACA CTGGGATCCTCCAGCCTGTG AAAGGTACGT 721 GTTTAAGCAT CCTCGACCTC CAAAACCTGA TGCTCCACGCATCTATGAGG CTCATGTGGG 781 GATGAGTGGT GAAGAGCCAG AAGTAAGCAC ATACAGAGAATTTGCAGACA ATGTGTTACC 841 ACGCATACGG GCAAATAACT ACAACACAGT TCAGTTAATGGCAATCATGG AACATTCCTA 901 CTATGCTTCT TTTGGGTATC ACGTGACAAA TTTTTTCGCAGTCAGCAGCA GATCAGGAAC 961 ACCAGAGGAT CTGAAATATC TTGTTGACAA GGCACATAGTTTAGGATTAC GAGTTCTGAT1021 GGATGTTGTC CATAGCCATG CGAGTAATAA TGTGACCGATGGTCTAAATG GCTATGACGT1081 TGGACAAAAC ACTCATGAGT CTTATTTTCA TACAGGAGATAGGGGCTACC ATAAACTCTG1141 GGATAGTCGT CTGTTCAACT ATGCCAATTG GGAGGTCTTAAGATTTCTTC TTTCTAATTT1201 GAGATATTGG ATGGACGAAT TCATGTTTGA TGGCTTCCGATTTGATGGGG TTACATCAAT1261 GCTATACCAT CACCATGGTA TCAATAAGGG ATTTACTGGAAACTACAAGG AGTATTTCAG1321 TTTGGATACC GATGTGGATG CAATTGTTTA CATGATGCTCGCAAACCATT TAATGCATAA1381 ACTCTTGCCG GAAGCAACTA TTGTTGCTGA AGATGTTTCGGGCATGCCAG TGCTTTGTCG1441 GCCAGTTGAT GAAGGTGGAG TAGGGTTTGA CTTCCGCCTGGCAATGGCCA TTCCTGATAG1501 ATGGATTGAC TACCTGAAGA ACAAAGAGGA CCGCAAATGGTCAATGAGTG AAATAGTGCA1561 AACTTTGACT AACAGGAGAT ATACAGAAAA ATGCATTGCCTATGCCGAGA GCCATGATCA1621 GTCCATTGTT GGTGACAAGA CTATAGCATT TCTCTTGATGGACAAGGAAA TGTACACTGG1681 CATGTCAGAC TTGCAGCCTG CTTCACCTAC CATCAACCGTGGCATTGCAC TCCAAAAGAT1741 GATTCACTTC ATTACGATGG CCCTTGGAGG TGATGGCTACTTAAATTTTA TGGGCAATGA1801 GTTTGGCCAT CCAGAATGGA TTGACTTTCC AAGAGAAGGCAACAACTGGA GCTATGATAA1861 ATGCAGACGT CAGTGGAGCC TTGTCGACAC TGATCACCTTCGATACAAGT ATATGAATGC1921 ATTTGATCAA GCAATGAATG CACTCGAGGA GGAATTTTCCTTCCTGTCAT CATCAAAGCA1981 GATTGTTAGC GACATGAACG AGAAAGATAA GGTTATTGTCTTTGAACGTG GAGATTTGGT2041 TTTTGTTTTC AATTTTCATC CCAACAAAAC TTATAAGGGTTACAAAGTCG GATGTGACTT2101 GCCCGGGAAG TACAGAGTAG CTCTGGACTG TGATGCTTTGGTCTTTGGTG GCCATGGAAG2161 AGTTGGCCAT GATGTGGATC ACTTCACGTC TCCCGAGGGAATGCCAGGAG TACCAGAAAC2221 AAATTTCAAC AACCGCCCTA ACTCATTCAA AGTCCTTTCCCCGCCCCGTA CCTGTGTGGC2281 TTACTATCGC GTTGATGAAG ATCGTGAAGA GCTCAGGAGGGGTGGAGCAG TTGCTTCTGG2341 AAAGATTGTT ACAGAGTATA TCGATGTTGA AGCAACAAGTGGGGAGACTA TCTCTGGTGG2401 CTGGAAGGGC TCCGAGAAGG ACGATTGTGG CAAGAAAGGGATGAAGTTTG TGTTTCGGTC2461 TTCTGACGAA GACTGCAAAT GAAGCATCAG ATTTCTTGATCAGGAGCAAC TGTTGGTGCC2521 CTTGTAATCT GGAGATCCTG GCTTGCCTTG GACTTGGTTGTGGTTCTTTA GCAGTTGCTA2581 TGTACCTATC TATGATATGA ACTTTATGTA TAGTTCGCCTTAAAGAAAGA ATAAGCAGTG2641 ATGATGTGGC CTTAAACCTG AGCTGCACAA GCCTAATGTAAAAATAAAGT TTCAGGCTTT2701 CATCCAGAAT AAAACAGCTG TTCATTTACC ATCTCAAAA

The invention is directed to food and food additive compositions comprising one or more human milk proteins produced in the seeds of a transgenic plant and methods of making the same. The invention is further directed to improved infant formula comprising such food supplement composition.

The invention overcomes the deficiencies of the prior art by providing methods for marker assisted selection to create plants of a soybean variety that exhibit a mid / low linolenic acid content with a commercially significant yield and an agronomically elite phenotype. The invention also provides derivatives and plant parts of these plants. Further provided by the invention are methods for the use of these plants. The invention is significant in that oil with decreased linolenic acid exhibits numerous beneficial characteristics yet prior art varieties with decreased linolenic acid also exhibited decreased yield and poor agronomic quality.

Oilseed plants which have been transformed to produce very long chain polyunsaturated fatty acids, recombinant constructs used in such transformations, methods for producing such fatty acids in a plant are described and uses of oils and seeds obtained from such transformed plants in a variety of food and feed applications are described.

The invention is directed to seed and seed extract compositions containing levels of a human milk protein between 3-40% or higher of the total protein weight of the soluble protein extractable from the seed. Also disclosed is a method of producing the seed with high levels of extractable human milk protein. The method includes transforming a monocotyledonous plant with a chimeric gene having a protein-coding sequence encoding a protein normally present in human milk under the control of a seed maturation-specific promoter. The method may further includes a leader DNA sequence encoding a monocot seed-specific transit sequence capable to target a linked milk protein to a storage body.

The invention is directed to food and food additive compositions comprising one or more human milk proteins produced in the seeds of a transgenic plant and methods of making the same. The invention is further directed to improved infant formula comprising such food supplement composition.

The invention is directed to blood proteins produced in monocot seeds and isolated therefrom for use in therapeutic compositions, and to methods of making these isolated blood proteins and to therapeutic compositions comprising them.

The invention overcomes the deficiencies of the prior art by providing methods for marker assisted selection to create plants of a soybean variety that exhibit a mid / low linolenic acid content with a commercially significant yield and an agronomically elite phenotype. The invention also provides derivatives and plant parts of these plants. Further provided by the invention are methods for the use of these plants. The invention is significant in that oil with decreased linolenic acid exhibits numerous beneficial characteristics yet prior art varieties with decreased linolenic acid also exhibited decreased yield and poor agronomic quality.

The invention relates to producing resveratrol glucoside in edible legume plants by transforming with a transgene encoding resveratrol synthase operably linked to a constitutive promoter. The invention relates to products containing and methods of using transformed edible legume plants and edible material of the transformed legume plants as a foodstuff, a nutritional supplement, an animal feed supplement or a nutraceutical. The invention further relates to a method of increasing disease resistance in an edible legume plant by transforming with a transgene encoding resveratrol synthase operably linked to a constitutive promoter.

This invention concerns a method of making an anti-infective composition for oral administration using an agent selected from the group consisting of lactoferrin protein and lysozyme protein. The method comprises three steps. The nucleic acid, which encodes a lactoferrin or lysozyme protein, is expressed in a monocot seed. The protein is isolated from the seed. This protein isolation compromises greater than 3% of the total soluble protein in the monocot seed. The protein is then formulated for oral administration.

Wheat having a reduced level of SBEIIa activity, that may have a relative high amylose content. Wheat having a mutant SBEIIa gene in the A genome. The wheat might additionally have reduced levels of SBEIIb activity. The wheat grain of this invention can be of a non-shrunken phenotype despite a lesion in the amylopectin synthesis pathway, and may also have a high relative amylose content.

The invention is directed to food and food additive compositions comprising one or more human milk proteins produced in the seeds of a transgenic plant and methods of making the same. The invention is further directed to improved infant formula comprising such food supplement composition.

The present invention relates to a process for the manufacture of a strained fermented dairy product, comprising a heat treatment step, a high pressure homogenization step, a fermentation step, a separation step and a smoothing step.

The invention overcomes the deficiencies of the prior art by providing methods for marker assisted selection to create plants of a soybean variety that exhibit a mid / low linolenic acid content with a commercially significant yield and an agronomically elite phenotype. The invention also provides derivatives and plant parts of these plants. Further provided by the invention are methods for the use of these plants. The invention is significant in that oil with decreased linolenic acid exhibits numerous beneficial characteristics yet prior art varieties with decreased linolenic acid also exhibited decreased yield and poor agronomic quality.

The invention relates to the technical field of an application of bacteroides fragilis (BF) 839, in particular to an application of the bacteroides fragilis 839 to preparation of a medicine or food for treating or adjunctively treating immune-related diseases. The key effect of the bacteroides fragilis 839 in human intestinal tracts in treatment or adjuvant treatment of the immune-related diseasesis discovered for the first time, and the bacteroides fragilis 839 can be made into forms of pharmaceutical compositions, foods, health-care products or food additives by utilizing the key effect ofthe bacteroides fragilis 839 in the immune-related diseases. A pharmaceutical composition, a food, a health-care product or a food additive contains the bacteroides fragilis 839, can be used for treating the immune-related diseases, and has very important application value.

Administration of modified transposon-based vectors has been used to achieve stable incorporation of exogenous genes into animals. These transgenic animals produce transgenic progeny. Further, these transgenic animals produce large quantities of desired molecules encoded by the transgene. Transgenic egg-laying animals produce large quantities of desired molecules encoded by the transgene and deposit these molecules in the egg.

The present invention relates to a plant cell which is genetically modified, the genetic modification leading to the reduction of the activity of one or more SSIII proteins which occur endogenously in the plant cell and to the reduction of the activity of one or more BEI proteins which occur endogenously in the plant cell and to the reduction of the activity of one or more BEII proteins which occur endogenously in the plant cell in comparison with corresponding plant cells, of wild-type plants, which have not been genetically modified. Further aspects of the invention relate to plants containing such plant cells, to a method for generating the plant cells and plants, and to the starch obtainable from them.

The present invention provides isolated and purified polynucleotide sequences encoding fatty acyl Co-A reductase (FAR) enzymes derived from wheat, designated TAA1 genes. The invention encompasses genes that encode FAR enzymes that are useful in the production of transgenic plants and other organisms that comprise increased or otherwise altered levels of fatty alcohols. Such plants may have significant commercial value for the production of fatty alcohols for use in nutritional and pharmaceutical compositions. The invention also provides corresponding TAA1 anther-specific promoters, suitable for the expression of proteins other than FAR enzymes in the anthers and pollen cells of suitably transformed plants.

The invention relates to a composition and method for prolonging the shelf life of banana by using interfering RNA. Said method transfers a control cassette for Musa spp. ACC oxidase into banana by a novel gene transfer method, wherein said composition comprises an interfering RNA, a gene transfer expression vector and pharmaceutically acceptable carrier. Said interfering RNA can inhibit / knock-down the mRNA expression of Musa spp. ACC oxidase and inhibit the biosynthesis of ethylene in banana, thereby delaying the ripening of banana, and consequently, prolonging the shelf life of banana.

Vegetable oils having an elevated stearic acid content and a low polyunsaturates content are described. A confectionery product containing oils of the invention is also described.

The invention provides a process of producing bio-available folate, i.e. folic acid having an increased proportion of monoglutamyl folate and a decreased proportion of polyglutamyl folate, by culturing micro-organisms containing an active heterologous or homologous polyglutamyl hydrolase activity or containing increased activities of folate biosynthesis enzymes. The genes encoding the polyglutamyl hydrolase and the folate biosynthesis enzymes may be of various origin, e.g. from rodents or other mammals including man. Also provided is a foodstuff, especially a dairy product containing such monoglutamyl folate-producing micro-organisms.

The present invention relates to monocotyledon plant ells and plants which are genetically modified, wherein the genetic modification consists of the introduction of an extraneous nucleic acid molecule which codes for a protein with the biological activity of an R1 protein. The present invention further relates to means and methods for the production thereof. Plant cells and plants of this type synthesise a modified starch, which is characterised in that is has an increased phosphate content and / or a modified phosphorylation pattern and / or an increased final viscosity in an RVA profile and / or a reduced peak temperature in DSC analysis and / or an increased gel strength in the texture analysis compared with starch from corresponding non-genetically modified monocotyledon plants. Therefore, the present invention also relates to the starch which is synthesised from the plant cells and plants according to the invention, and to methods of producing said starch. The present invention further relates to wheat flours which contain said modified starches, and to food products and bakery products which contain said wheat flours and / or starch.